Archive — US — techcrunch
Phantom Neuro grabs $19M to help amputees put their phantom limbs to use
Phantom Neuro has secured $19 million in funding to advance its skin-implanted wristband technology that enables amputees to control prosthetic limbs. The startup has achieved FDA Breakthrough Device designation and demonstrated 94% accuracy in translating nerve impulses to prosthetic movement. With plans to expand into leg prosthetics and robotic controls, the innovation aims to enhance functionality for users.
Key points
- Phantom Neuro raised $19 million to develop its implantable wristband device.
- The device helps amputees control prosthetics by interpreting nerve impulses.
- Achieved FDA designations as a Breakthrough Device and for TAP, streamlining commercialization.
- Reported 94% accuracy in recent studies for 11 hand/wrist movements.
- Restoration of up to 85% functionality can be achieved with 10 minutes of calibration.
- Ottobock and other investors are backing the venture, indicating strong strategic support.
- Phantom Neuro aims to extend technology applications beyond amputees to robotics as well.
Why it matters
- This aligns with the 2025 IT trends focusing on health tech innovation through implantable devices.
- The development of brain-computer interfaces and neural networks is gaining traction in the tech field.
- The trend of reducing invasiveness in medical devices reflects a growing demand for patient-friendly technologies.
- Advances in prosthetics using AI and machine learning signify a shift towards more intuitive and adaptive healthcare solutions.
Phantom Neuro's funding and advancements represent a significant leap in prosthetic technology, enabling improved quality of life for amputees and potentially revolutionizing human-machine interactions in the future.